Factors affecting quality of life in patients with neovascular age-related macular degeneration

Benjamin Sommer Thinggaard, Yousif Subhi, Fadumo Abdullah Ismail, Maria Kjøller Pedersen, Lars Morsø, Jakob Grauslund, Lonny Stokholm

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

This study examines how factors such as age, sex, best corrected visual acuity (BCVA), driving ability, and perceived treatment effectiveness influence quality of life (QoL) among patients with neovascular age-related macular degeneration (nAMD) in treatment with anti-vascular endothelial growth factor (VEGF) injections. Such information might be invaluable for healthcare providers, enabling them to understand who benefits from treatment.
Original languageEnglish
Article number100066
JournalAJO International
Volume1
Issue number3
DOIs
Publication statusPublished - 3 Oct 2024

Fingerprint

Dive into the research topics of 'Factors affecting quality of life in patients with neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Cite this